LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (LIXT)

CUSIP: 539319301

Q3 2023 13F Holders as of 30 Sep 2023

Security identity
Shares outstanding
2,666,933
Holder snapshot
Share change
+20,643
Reported price per share
$2.45
Number of holders
6
Value change
+$15,777
Number of buys
5
Number of sells
2

Security key

539319301

Report period

Q3 2023

Institutions

6

Top holders

6

Ownership snapshot

Top shareholders of LIXT - LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
GEODE CAPITAL MANAGEMENT,...
13D/G signal
Evidence rows
12
Latest as of
30 Jun 2023
13F 3/4/5 Lead comparable stake: 0.38% Showing first 8 of 12 holder rows. Open remaining rows
Holder Evidence Ownership % Position 12M Net Δ As of
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.38%
$58,993
10,119 shares
30 Jun 2023
MORGAN STANLEY
13F
Company
13F
0.27%
$41,783
7,106 shares
30 Jun 2023
UBS Group AG
13F
Company
13F
0%
$594
101 shares
30 Jun 2023
Tower Research Capital LLC (TRC)
13F
Company
13F
0%
$47
8 shares
30 Jun 2023
WELLS FARGO & COMPANY/MN
13F
Company
13F
0%
$35
6 shares
30 Jun 2023
Glenn Krinsky
3/4/5
10%+ Owner
class O/S missing
$3,702,245
1,474,998 shares
17 Dec 2021
Gil Schwartzberg
3/4/5
Director, 10%+ Owner
class O/S missing
$2,952,733
1,176,388 shares
31 Dec 2021
Ethos Financial Group, LLC
13F
Company
13F
class O/S missing
$205,240
248,084 shares
30 Jun 2023
Show 4 additional holder rows in the full holder list
Holder Evidence Ownership % Position 12M Net Δ As of
John S. Kovach
3/4/5
President and CEO, Director
mixed-class rows
221,100 shares
mixed-class rows
06 Nov 2022
James Miser
3/4/5
Chief Medical Officer
class O/S missing
200,000 shares
06 Nov 2022
Robert N. Weingarten
3/4/5
Vice President and CFO
class O/S missing
200,000 shares
06 Nov 2022
Philip F. Palmedo
3/4/5
Director
mixed-class rows
137,720 shares
mixed-class rows
30 Jun 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
6
Shares
37,983
Rows loaded
6
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
5
Q3 2023 holders
6
Holder diff
1
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 value Q3 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .